Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J ASEAN Fed Endocr Soc ; 39(1): 106-114, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38863920

RESUMO

Objective: This study aimed to evaluate the effects of the combination of curcumin and piperine supplementation on Fasting Plasma Glucose (FPG), Homeostatic Model of Insulin Resistance (HOMA-IR), and Body Mass Index (BMI) in patients with prediabetes and type 2 Diabetes Mellitus (T2DM). This review was done to identify potential herbal remedies that may help improve glycemic parameters, leading to better health outcomes in combination with current antidiabetic treatment. Methodology: This systematic review was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). It was conducted in 2023 with sources and databases from MEDLINE, EBSCO-Host, ScienceDirect and ProQuest. This paper included randomized-controlled trials exploring the effects of the combination of curcumin and piperine on patients with prediabetes and T2DM. Systematic reviews, observational studies, case reports, case series, conference abstracts, book sections, commentaries/editorials, non-human studies and articles with unavailable full-text and written in non-English language, were excluded. The key terms for the literature search were "curcumin," "piperine," "prediabetes" and "Type 2 Diabetes Mellitus." We use Cochrane Risk of Bias (RoB) 2 for quality assessment of the included studies and Review Manager (RevMan) 5.4 to do the meta-analysis. Results: A total of three studies were included in this systematic review. Two studies from Neta et al., and Cicero et al., showed no significant difference in HOMA-IR, BMI and FPG levels between the curcumin, piperine and placebo groups. One study from Panahi et al. demonstrated a significant difference in BMI levels between the curcumin and piperine and placebo groups (p <0.01). The meta-analysis showed that FPG levels, HOMA-IR and BMI improved among patients with diabetes given in curcumin and piperine with reported mean differences (MD) of = -7.61, 95% CI [-15.26, 0.03], p = 0.05, MD = -0.36, 95% CI [-0.77 to 0.05], p = 0.09, and MD = -0.41, 95% CI [-0.85 to 0.03], p = 0.07, respectively). Conclusions: The supplementation of curcumin and piperine showed a numerical reduction in FPG, HOMA-IR and BMI, but were not statistically significant. Further research is needed as there is a paucity of studies included in the review.


Assuntos
Alcaloides , Benzodioxóis , Curcumina , Diabetes Mellitus Tipo 2 , Piperidinas , Alcamidas Poli-Insaturadas , Estado Pré-Diabético , Humanos , Alcaloides/administração & dosagem , Alcaloides/farmacologia , Alcaloides/uso terapêutico , Benzodioxóis/uso terapêutico , Benzodioxóis/administração & dosagem , Benzodioxóis/farmacologia , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Glicemia/análise , Curcumina/uso terapêutico , Curcumina/farmacologia , Curcumina/administração & dosagem , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/sangue , Suplementos Nutricionais , Quimioterapia Combinada , Resistência à Insulina , Piperidinas/farmacologia , Piperidinas/uso terapêutico , Piperidinas/administração & dosagem , Alcamidas Poli-Insaturadas/farmacologia , Alcamidas Poli-Insaturadas/administração & dosagem , Estado Pré-Diabético/tratamento farmacológico , Estado Pré-Diabético/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...